Vesalio’s enVast Meets NATURE Trial Endpoint in STEMI
Dallas, Texas, August 29, 2026 Vesalio announced positive results from the NATURE randomized controlled trial, evaluating the company’s enVast™...
Mechanical Thrombectomy
Advertisement
Philips Wins $33.7M ARPA-H Award for Robotic Stroke Care
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
Penumbra THUNDERBOLT Shows Strong Stroke Trial Results
ALAMEDA, California, July 22, 2026 Penumbra, Inc. has announced positive results from the THUNDER Investigational Device Exemption (IDE) study,...
Rapid Medical Receives FDA Clearance for DRIVEWIRE 35
SEATTLE & YOKNEAM, Israel, July 21, 2026 Rapid Medical announced U.S. Food and Drug Administration (FDA) clearance of DRIVEWIRE™...
Akston Reports Positive Canine Osteoarthritis Study Results
BEVERLY, Mass., July 7, 2026 Akston Biosciences Corporation has announced encouraging preclinical data demonstrating that its investigational NGF-targeting Ambifect®...
Advertisements
Penumbra Enrolls First Patient in FORWARD Stroke Study
ALAMEDA, Calif., July 7, 2026 Penumbra, Inc., a global leader in thrombectomy technologies, has announced the first patient enrollment...
J&J Expands Stroke Care with CEREGLIDE System
IRVINE, Calif., February 26, 2026 Johnson & Johnson announced the U.S. launch of CEREGLIDE™ 42, CEREGLIDE™ 57 aspiration catheters,...
Vesalio Expands Neurovascular Portfolio with CE, FDA Nod
Plano, Texas — February 10, 2026: Vesalio, a global vascular intervention medical device company, announced major regulatory and commercial...
Advertisement
